undamentalytics Newsletter
Sign in

DBV Technologies S.a. balance sheet

At the end of fiscal 2025, DBV Technologies S.a. had total assets of $234m, total liabilities of $64.9m and shareholders' equity of $169m. It held $194m in cash against $0 of debt: net cash of $194m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMSept 2026
Cash and equivalents1931967720914132194166
Receivables—2000———
Inventory20——————
Total current assets20520711422315944213190
Total assets27227214724718366234215
Total current liabilities5453313037315859
Short-term debt1———————
Long-term debt111———00
Total debt111—0000
Total liabilities7967475243386567
Shareholders' equity1932059919414027169149
Net debt (negative = net cash)−192−195−77−209−141−32−194−166
Shares outstanding—————103m——

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: DBVT vs DYAIALGS vs DBVTCAMP vs DBVT

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from DBV Technologies S.a.'s SEC filings (10-K and 10-Q), retrieved October 31, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to DBV Technologies S.a.